ImmPACT Bio

ImmPACT Bio

生物技术研究

West Hills,California 7,691 位关注者

We are developing advanced therapies for cancer patients with critical unmet needs

关于我们

ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility.

网站
immpactbio.com
所属行业
生物技术研究
规模
51-200 人
总部
West Hills,California
类型
私人持股
创立
2017
领域
CAR-T、Immunotherapy、Cancer Therapy、On target off tumor toxicity 、Selective treatment 、Logic gate、Oncology、Biotechnology、Research、Immunotherapy、autoimmune和lupus

地点

ImmPACT Bio员工

动态

相似主页

查看职位